For one composite 86-year-old man, NU553's Unit 10 deprescribing plan reduces insulin first, stops a statin next and tapers a proton pump inhibitor last, ordering the changes by risk. Searches like "nu 553 unit 10 assignment example", "nu553 unit 10 sample" and "nu553 unit 10 example" land here.
What a finished NU553 Unit 10 deprescribing plan looks like
Four pages hold three pieces: an eleven-row table, a plan in sequence and a grid of checks. The table gives all eleven agents with indication, expected benefit, present harm and a verdict. Three agents change. Insulin glargine is reduced first, because an A1C of [6.1] percent and two low readings in [eight] weeks show a target set for a younger man, and the plan cites the ADA's annual Standards of Care, by edition year, for less stringent goals in older adults with complex health. Atorvastatin, taken for primary prevention, stops next, supported by the 2015 trial by Kutner and colleagues in adults with limited life expectancy. Pantoprazole, continued [six] years after esophagitis healed, is tapered last, following the 2017 evidence-based deprescribing guideline by Farrell and colleagues to limit rebound acid.
How a NU553 Unit 10 example is structured
The plan is sequenced by the harm each agent is causing now, not by how easy it is to stop. Hypoglycemia in a man living alone is the most immediate danger, so insulin changes first, with home glucose checks and a relaxed target written down. The statin follows because it can stop without tapering and its benefit depends on years he may not have; the plan says this plainly and records that the daughter and patient agreed after hearing it. The proton pump inhibitor comes last because its taper takes weeks and rebound heartburn could be mistaken for the original disease. Changes are spaced so that any new symptom points back to a single step. A continuing section explains why the other eight agents stay, each in a sentence, and the plan closes with what would reverse any step.
Insulin set for a younger body
An A1C of [6.1] percent with two lows is overtreatment at [86]. The plan reduces glargine by a bracketed fraction, sets a looser target, and asks for morning glucose readings, logged with his daughter's help, for [two] weeks.
A statin whose payoff is years away
Primary prevention statins pay back over years. With [three] heart failure admissions this year, the plan stops atorvastatin without a taper and cites the 2015 discontinuation trial, stating what the evidence showed and what it did not.
Checking the taper is allowed
The 2017 PPI guideline excludes Barrett esophagus and severe esophagitis. His endoscopy showed [mild] disease, so the plan records that finding before stepping pantoprazole down to [every other day] and then to use as needed.
Rebound heartburn, predicted in advance
Acid secretion can rebound for a few weeks after a proton pump inhibitor stops. The plan warns the family in writing so that a week of heartburn is not read as proof that the drug was needed.
The eight that stay
Heart failure agents, his [antihypertensive] and a nightly [eye drop] each keep their place with a one-line reason. Showing what continues makes the plan read as judgment rather than as a campaign against pills.
Where marks go in NU553 Unit 10
Deprescribing plans are graded on whether each change is justified, sequenced and monitored. A plan that stops all three agents in the same week cannot tell which change caused a problem, a safety fault graders notice. Ordering by convenience instead of harm, stopping the statin first because it is easy while hypoglycemia continues, misses the point of sequencing. Abrupt withdrawal of the proton pump inhibitor, with no mention of rebound, loses method marks, as does tapering it without checking the guideline's exclusions. The insulin change needs a new target stated in numbers; relaxing control without saying to what reads as neglect. A deprescribing guideline cited without its year or scope draws a comment. Leaving out what the patient and his daughter want, or listing only what stops and never what stays, completes the usual deductions.
Get a NU553 Unit 10 example written to your instructions
Only four things are needed from an NU553 Unit 10 deprescribing case: the medication list, the history, any goals the patient or family have voiced, and the rubric. Expect the first plan free, within 24-48h: each change justified with dated evidence, sequenced by current harm, given its own method and monitoring, and set beside a reasoned list of what stays.
NU553 Unit 10 questions, answered
How many medications should a deprescribing plan change?
As many as the evidence supports, but usually not all at once. Most cases reward choosing the few agents with the clearest harm and sequencing them, rather than attempting a complete overhaul in one visit. The sample changes three of eleven and explains why the rest continue, which shows judgment in both directions.
Which criteria should a deprescribing plan cite?
It depends on the drug. The AGS Beers Criteria and STOPP/START flag potentially inappropriate medications broadly, while drug-specific deprescribing guidelines, such as the 2017 proton pump inhibitor guideline, describe how to stop. The sample uses the drug-specific sources because the plan's question is method as much as whether, and each citation carries its year.
What if the patient does not want to stop a medicine?
Then the plan records that preference and respects it, with the reasoning the patient heard. Deprescribing is a shared decision, and a plan that overrides a clear refusal fails on ethics however sound the pharmacology. The sample notes the daughter's question and the patient's agreement, and it describes how the conversation about the statin was framed.